Sciensus names John Gillie as CFO amid European expansion

By AI, Created 12:21 PM UTC, June 01, 2026, /AGP/ – Sciensus has appointed veteran life sciences executive John Gillie as chief financial officer, effective June 1, 2026, as the UK home-care provider expands its connected care model and European partnerships. The move is aimed at strengthening financial leadership while the business scales across NHS, pharmaceutical and private pathways.

Why it matters: - Sciensus is expanding beyond its UK base and needs tighter financial leadership as it scales across Europe. - The CFO hire comes as Sciensus invests more in digital platforms that support care delivery and evidence generation. - Stronger board-level finance oversight matters because Sciensus is diversifying across NHS, pharma and private channels.

What happened: - Sciensus appointed John Gillie as chief financial officer, effective 1 June 2026. - Gillie joins Sciensus after serving as chief executive officer at Quinecsa Solutions. - Sciensus described Gillie as an experienced life sciences finance leader.

The details: - Gillie has more than 34 years of experience in pharma services and life sciences. - He has 15 years of board-level experience in private equity-backed businesses. - His career includes CFO, COO and CEO roles across Europe, North America and Asia Pacific. - At Envision Pharma, Gillie spent 17 years and helped lead a management buyout. - Envision Pharma tripled turnover over eight years during his tenure, with about 75% of that growth coming organically alongside international expansion. - Gillie previously spent 12 years at Parexel. - Sciensus Interim Chief Executive Officer Gordon Cox said Gillie brings financial and operational experience that fits Sciensus’ growth plans. - Gillie said he was drawn to Sciensus because the company has a direct and immediate impact on patients.

Between the lines: - The appointment signals that Sciensus expects growth to keep accelerating, not just in the UK but across Europe. - Gillie’s background suggests Sciensus wants a CFO who can pair financial discipline with operational scaling. - The focus on patient impact and evidence generation points to a business model that is becoming more data-driven as well as more geographically complex.

What’s next: - Sciensus is continuing to expand partnerships with NHS systems and biopharma companies. - The company is also increasing investment in the digital infrastructure behind its care model. - Gillie is expected to help support the next phase of growth as Sciensus broadens its commercial model across multiple pathways.

The bottom line: - Sciensus is adding a seasoned life sciences executive to its leadership team as it pushes deeper into European growth and digital-enabled care.